Terrific cells for SARS-CoV-2

por Gottschalk, Stephen
Publicado 2022

Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors

por Mata, Melinda, Gottschalk, Stephen
Publicado 2019

Engineered Cytokine Signaling to Improve CAR T Cell Effector Function

por Bell, Matthew, Gottschalk, Stephen
Publicado 2021

Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update

por DeRenzo, Christopher, Gottschalk, Stephen
Publicado 2016

Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors

por DeRenzo, Christopher, Gottschalk, Stephen
Publicado 2019

A tour de force provides novel insights into CD19-CAR T cell resistance mechanisms

por Talleur, Aimee C., Gottschalk, Stephen
Publicado 2023

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy

por Epperly, Rebecca, Gottschalk, Stephen, Velasquez, M. Paulina
Publicado 2020

Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond

por Epperly, Rebecca, Gottschalk, Stephen, Velasquez, Mireya Paulina
Publicado 2020

Allogeneic CAR Cell Therapy—More Than a Pipe Dream

por Caldwell, Kenneth J., Gottschalk, Stephen, Talleur, Aimee C.
Publicado 2021

Adapting an immune competent mouse model for glioblastoma T cell therapy

por Rodriguez-Cruz, Tania, Yi, Zhongzhen, Gottschalk, Stephen, Krebs, Simone
Publicado 2014

MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy

por Mata, Melinda, Gerken, Claudia, Spencer, David M, Gottschalk, Stephen
Publicado 2015

T Cell-Biased Immune Responses Generated by a Mucosally-targeted Adenovirus-Sigma 1 Vaccine

por Weaver, Eric A., Mercier, George T., Gottschalk, Stephen, Barry, Michael A.
Publicado 2012

Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models

por Csaplár, Marianna, Szöllősi, János, Gottschalk, Stephen, Vereb, György, Szöőr, Árpád
Publicado 2021

A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading

por Gottschalk, Stephen, Yu, Feng, Ji, Minjun, Kakarla, Sunitha, Song, Xiao-Tong
Publicado 2013

Genetically Modified T Cells to Target Glioblastoma

por Krebs, Simone, Rodríguez-Cruz, Tania G., DeRenzo, Christopher, Gottschalk, Stephen
Publicado 2013

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma

por Yi, Zhongzhen, Prinzing, Brooke L., Cao, Felicia, Gottschalk, Stephen, Krenciute, Giedre
Publicado 2018

IMMU-05. B7-H3-SPECIFIC CAR T CELLS HAVE POTENT ANTI-TUMOR ACTIVITY IN THE GL261 IMMUNE-COMPETENT MURINE BRAIN TUMOR MODEL

por Haydar, Dalia, Yi, Zhongzhen, DeRenzo, Chris, Gottschalk, Stephen, Krenciute, Giedre
Publicado 2020

Unifying heterogeneous expression data to predict targets for CAR-T cell therapy

por Schreiner, Patrick, Velasquez, Mireya Paulina, Gottschalk, Stephen, Zhang, Jinghui, Fan, Yiping
Publicado 2021

MyD88/CD40 signaling retains CAR T cells in a less differentiated state

por Prinzing, Brooke, Schreiner, Patrick, Bell, Matthew, Fan, Yiping, Krenciute, Giedre, Gottschalk, Stephen
Publicado 2020

IMMU-01. Combining CD28 and 4-1BB costimulationin trans enhances the anti-glioma efficacy and persistence of B7-H3 CAR T cells in immune-competent brain tumor models

por Haydar, Dalia, Elayan, Abdul, Yi, Zhongzhen, Gottschalk, Stephen, DeRenzo, Chris, Krenciute, Giedre
Publicado 2022